期刊文献+

The impact analysis of the oxidative stress injury and inflammatory factor level for ticagrelor assisted PCI in the treatment the elderly patients with ST segment elevation acute myocardial infarction

下载PDF
导出
摘要 Objective:To investigate the effect of ticagrelor assisted PCI in treatment the elderly patients with acute ST elevation myocardial infarction (STEMI) on oxidative stress and inflammatory factor level.Methods:A total of 100 cases elderly patients with STEMI were selected that they were being treated with PCI. According to the digital list method was divided into the study group and control group, and 50 cases in each group. The control group was treated with PCI and the strong heart, anticoagulation, vasodilation, prevention of infection and other comprehensive treatment of myocardial infarction, the study group were given ticagrelor treatment which was based on the comprehensive treatment of myocardial infarction. The level change were compared that oxidative stress index (MDA), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) activity and inflammatory factor hypersensitive C reactive protein (hs-CRP), N-terminal pro brain natriuretic peptide (NT-proBNP) and interleukin -6 (IL-6) between the two groups in before treatment (T0), treatment with 7 d (T1), 14 d (T2), 30 d (T3).Results:(1)There was no significant difference in serum MDA, GSH-Px and SOD levels between the two groups in the T0. Two groups serum MDA level were higher than theT0, and the GSH-Px and SOD levels were lower than the T0 after operation in the T1.And the serum MDA level were lower than T0, T1, GSH-Px and SOD levels were higher than T0, T1in the T2, T3.The T3 serum MDA level was lower than T2, GSH-Px and SOD levels were higher than T2.Even the serum MDA was significantly lower than the control group T1, T2, T3 and the GSH-Px and SOD were higher than those of the control group T1, T2, T3 at the study groupT1, T2, T3, the difference was statistically significant. (2)There was no significant difference in T0 of the serum hs-CRP, IL-6 and NT-proBNP levels between the two groups. Two groups serum hs-CRP, IL-6 and NT-proBNP level were higher than the T0 after operation in the T1.And the serum hs-CRP, IL-6 and NT-proBNP levels were higher than T0, T1in the T2, T3.The T3 serum hs-CRP, IL-6 and NT-proBNP levels were lower than T2.and that the serum hs-CRP, IL-6 and NT-proBNP levels were significantly lower than the control group T1, T2, T3 at the study groupT1, T2, T3, so the difference was statistically significant.Conclusion:The treatment method will be able to reduce oxidative stress injury and effectively control the inflammatory response that ticagrelor assisted PCI in treatment the elderly patients with acute ST elevation myocardial infarction (STEMI).
出处 《Journal of Hainan Medical University》 2017年第11期17-20,共4页 海南医学院学报(英文版)
  • 相关文献

二级参考文献79

  • 1Iliodromitis EK, Andreadou I, Markantonis - Kyroudis S, et al. The effects of tirofiban on peripheral markers of oxidative stress and endothe- lial dysfunction in patients with acute coronary syndromes [ J ]. Thromb Res, 2007, 119 (2): 167-174.
  • 2Labinaz M, Ho C, Banerjee S, et al. Meta - analysis of clinical efficacy and bleeding risk with intravenous glycoprotein ]I b/I a an tagonists for percutaneous coronary intervention [ J ]. Can J Cardiol, 2007, 23 (12) : 963 -970.
  • 3Martfnez- Rfos MA, Rosas M, Gonzez H, et al . Comparison of reperfusion regimens with or without tirofiban in ST - elevation acute myocardiao infarction [ J ]. Am J Cardiol, 2004, 93 ( 3 ) : 280 - 287.
  • 4Mega JL, Morrow DA, De Lemos JA, et al. B - type natriuretic peptide at presentation and prognosis in patients with ST - segment elevation my- ocardial infarction: an ENTIRE- TIMI- 23 substudy [ J]. J Am Coil Cardiol, 2004, 44 (2): 335-339.
  • 5Gibson CM. Has my patient achieved adequate myocardial reperfusion? [J] . Circulation, 2003, 108 (5) : 504 -507.
  • 6Valgimigli M, Biondi - Zoccai G, Tebaldi M, et al. Tirofiban as ad- junctive therapy for acute coronary syndromes and pereutaneous coronary intervention: a meta analysis of randomized trials [ J ]. Eur Heart J, 2010. 31 (1): 35-49.
  • 7姚懿,袁晋青.新型抗血小板药物普拉格雷、替格瑞洛与氯吡格雷的临床对比研究进展[J].中华临床医师杂志(电子版),2013,7(19):8870-8873.
  • 8Schleicher E, Friess U. Oxidative stress, age and atherosclerosis [ J. Kidney Int Suppl,2007,106 ( 8 ) : 17 - 26.
  • 9Dworakowski R, Alom-Ruiz SP, Shah AM. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype [ J 3. Pharmacol Rep,2008,60 ( 1 ) : 21 - 28.
  • 10Nathan C,Cunningham-Bussel A. Beyond oxidative stress:an im- munologist guide to reactive oxygen species[ J]. Nat Rev Immu- no1,2013,13 (5) :349 - 361.

共引文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部